Stoke Therapeutics, Inc. (NASDAQ:STOK) Stock Has Average Target Price of $44.25

Stoke Therapeutics, Inc. (NASDAQ:STOK) Stock Has Average Target Price of $44.25

Stoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) has earned a consensus rating of "Moderate Buy" from the eleven ratings firms that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation and ten have assigned a bu

Monopar Therapeutics Inc. (NASDAQ:MNPR) Stock Has Average Target Price of $122.00

Monopar Therapeutics Inc. (NASDAQ:MNPR – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten ratings firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, six have assigned a buy rating and one has […]